| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 22,004,000 | 20,454,000 | 20,156,000 | 20,272,000 | | Cost of Revenue | 16,974,000 | 28,533,000 | 15,330,000 | 12,713,000 | | | Gross Profit | 5,030,000 | (8,079,000) | 4,826,000 | 7,559,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,128,000 | (9,617,000) | 2,974,000 | 6,643,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 234,000 | 259,000 | 254,000 | 243,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,668,000 | 1,279,000 | 1,598,000 | 673,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,668,000 | 1,279,000 | 1,598,000 | 673,000 | | Interest Expense | 131,000 | 155,000 | 166,000 | 164,000 | | Income Before Tax | 1,537,000 | 1,124,000 | 1,432,000 | 509,000 | | Income Tax Expense | 553,000 | 398,000 | 512,000 | 172,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 984,000 | 726,000 | 920,000 | 337,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 984,000 | 726,000 | 920,000 | 337,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $984,000 | $726,000 | $920,000 | $337,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
